Combined Fluocinolone Acetonide Sustained Drug Delivery System Implantation and Phacoemulsification/Intraocular Lens Implantation in Patients With Severe Uveitis

NCT00570830 NA COMPLETED

To review chart data at the Duke Eye Center and determined whether a 3-year fluocinolone acetonide sustained drug delivery system (FA) safely suppressed postoperative inflammation when combined with phacoemulsification and posterior chamber intraocular lens implantation (phaco/PCIOL) in eyes with severe uveitis.

Details

Lead sponsor	Duke University
Phase	NA
Status	COMPLETED
Enrolment	21
Start date	2006-09
Completion	2008-05

Conditions

• Intermediate Uveitis
• Posterior Uveitis

Interventions

• Retisert (fluocinolone acetonide implant)

Primary outcomes

• Preoperative and postoperative ocular inflammation — up to 12 months postoperatively

Countries

United States